Literature DB >> 25548233

Effector T cells boost regulatory T cell expansion by IL-2, TNF, OX40, and plasmacytoid dendritic cells depending on the immune context.

Audrey Baeyens1, David Saadoun1, Fabienne Billiard1, Angéline Rouers1, Sylvie Grégoire1, Bruno Zaragoza1, Yenkel Grinberg-Bleyer1, Gilles Marodon1, Eliane Piaggio1, Benoît L Salomon2.   

Abstract

CD4(+)CD25(+)Foxp3(+) regulatory T (Treg) cells play a major role in peripheral tolerance. Multiple environmental factors and cell types affect their biology. Among them, activated effector CD4(+) T cells can boost Treg cell expansion through TNF or IL-2. In this study, we further characterized this effector T (Teff) cell-dependent Treg cell boost in vivo in mice. This phenomenon was observed when both Treg and Teff cells were activated by their cognate Ag, with the latter being the same or different. Also, when Treg cells highly proliferated on their own, there was no additional Treg cell boost by Teff cells. In a condition of low inflammation, the Teff cell-mediated Treg cell boost involved TNF, OX40L, and plasmacytoid dendritic cells, whereas in a condition of high inflammation, it involved TNF and IL-2. Thus, this feedback mechanism in which Treg cells are highly activated by their Teff cell counterparts depends on the immune context for its effectiveness and mechanism. This Teff cell-dependent Treg cell boost may be crucial to limit inflammatory and autoimmune responses.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25548233     DOI: 10.4049/jimmunol.1400504

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

Review 1.  Strategies for combining immunotherapy with radiation for anticancer therapy.

Authors:  Steven N Seyedin; Jonathan E Schoenhals; Dean A Lee; Maria A Cortez; Xiaohong Wang; Sharareh Niknam; Chad Tang; David S Hong; Aung Naing; Padmanee Sharma; James P Allison; Joe Y Chang; Daniel R Gomez; John V Heymach; Ritsuko U Komaki; Laurence J Cooper; James W Welsh
Journal:  Immunotherapy       Date:  2015-08-27       Impact factor: 4.196

2.  OX40L-JAG1-Induced Expansion of Lineage-Stable Regulatory T Cells Involves Noncanonical NF-κB Signaling.

Authors:  Prabhakaran Kumar; Swarali Surendra Lele; Vandhana K Ragothaman; Divya Raghunathan; Alan L Epstein; Shigeru Chiba; Bellur S Prabhakar
Journal:  J Immunol       Date:  2019-11-08       Impact factor: 5.422

3.  The probacterial effect of type I interferon signaling requires its own negative regulator USP18.

Authors:  Namir Shaabani; Nadine Honke; Nhan Nguyen; Zhe Huang; Kei-Ichiro Arimoto; Daniel Lazar; Taylor K Loe; Karl S Lang; Marco Prinz; Klaus-Peter Knobeloch; Dong-Er Zhang; John R Teijaro
Journal:  Sci Immunol       Date:  2018-09-28

4.  Critical role of OX40 signaling in the TCR-independent phase of human and murine thymic Treg generation.

Authors:  Prabhakaran Kumar; Alejandra Marinelarena; Divya Raghunathan; Vandhana K Ragothaman; Shikha Saini; Palash Bhattacharya; Jilao Fan; Alan L Epstein; Ajay V Maker; Bellur S Prabhakar
Journal:  Cell Mol Immunol       Date:  2018-03-26       Impact factor: 11.530

5.  Serum C-Reactive Protein and Congestive Heart Failure as Significant Predictors of Herpes Zoster Vaccine Response in Elderly Nursing Home Residents.

Authors:  Chris P Verschoor; Alina Lelic; Robin Parsons; Carole Evelegh; Jonathan L Bramson; Jennie Johnstone; Mark B Loeb; Dawn M E Bowdish
Journal:  J Infect Dis       Date:  2017-07-15       Impact factor: 5.226

Review 6.  A comprehensive review on the role of co-signaling receptors and Treg homeostasis in autoimmunity and tumor immunity.

Authors:  Prabhakaran Kumar; Palash Bhattacharya; Bellur S Prabhakar
Journal:  J Autoimmun       Date:  2018-08-31       Impact factor: 7.094

7.  Potent Immune Modulation by MEDI6383, an Engineered Human OX40 Ligand IgG4P Fc Fusion Protein.

Authors:  Michael D Oberst; Catherine Augé; Chad Morris; Stacy Kentner; Kathy Mulgrew; Kelly McGlinchey; James Hair; Shino Hanabuchi; Qun Du; Melissa Damschroder; Hui Feng; Steven Eck; Nicholas Buss; Lolke de Haan; Andrew J Pierce; Haesun Park; Andrew Sylwester; Michael K Axthelm; Louis Picker; Nicholas P Morris; Andrew Weinberg; Scott A Hammond
Journal:  Mol Cancer Ther       Date:  2018-03-15       Impact factor: 6.261

Review 8.  Restoring self-tolerance in autoimmune diseases by enhancing regulatory T-cells.

Authors:  Prabhakaran Kumar; Shikha Saini; Saad Khan; Swarali Surendra Lele; Bellur S Prabhakar
Journal:  Cell Immunol       Date:  2018-09-29       Impact factor: 4.868

Review 9.  Phenotypical characterization of regulatory T cells in humans and rodents.

Authors:  A L Rodríguez-Perea; E D Arcia; C M Rueda; P A Velilla
Journal:  Clin Exp Immunol       Date:  2016-08-01       Impact factor: 4.330

Review 10.  Insights into the biology and therapeutic implications of TNF and regulatory T cells.

Authors:  Benoit L Salomon
Journal:  Nat Rev Rheumatol       Date:  2021-07-05       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.